Abstract: The present invention relates to compositions comprising combinations of biologically active proteins linked to extended recombinant polymer, methods of production of the compositions and their use in treatment of metabolic and cardiovascular diseases, disorders and conditions.
Type:
Application
Filed:
December 21, 2010
Publication date:
December 22, 2011
Applicant:
AMUNIX, Inc.
Inventors:
Joshua Silverman, Volker Schellenberger, Willem P. Stemmer, Jeffrey L. Cleland
Abstract: The present invention relates to compositions comprising growth hormone linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of growth hormone-related diseases, disorders, and conditions.
Type:
Application
Filed:
June 8, 2010
Publication date:
March 31, 2011
Applicant:
Amunix, Inc.
Inventors:
Volker Schellenberger, Joshua Silverman, Chia-wei Wang, Willem P. Stemmer, Nathan Geething
Abstract: The present invention relates to compositions comprising glucose regulating peptides linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of glucose regulating peptide-related diseases, disorders, and conditions.
Type:
Application
Filed:
June 8, 2010
Publication date:
December 23, 2010
Applicant:
AMUNIX, INC.
Inventors:
Volker Schellenberger, Joshua Silverman, Chia-wei Wang, Willem P. Stemmer, Nathan Geething